Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert R Luedtke

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Journal of Labelled Compounds & Radiopharmaceuticals|September 1, 2017
Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studiesRobert H Mach, Robert R Luedtke
The Journal of Biological Chemistry|July 13, 2004
D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascadeJun Chen, Milan Rusnak, Robert R Luedtke, et al.
Journal of Chemical Information and Modeling|October 13, 2010
Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methodsQi Wang, Robert H Mach, Robert R Luedtke, et al.
Pharmacology, Biochemistry, and Behavior|July 12, 2016
The effect of the sigma-1 receptor selective compound LS-1-137 on the DOI-induced head twitch response in miceManinder Malik, Claudia Rangel-Barajas, Robert H Mach, et al.
Neuropharmacology|February 21, 2015
Pharmacological modulation of abnormal involuntary DOI-induced head twitch response movements in male DBA/2J mice: II. Effects of D3 dopamine receptor selective compoundsClaudia Rangel-Barajas, Maninder Malik, Robert H Mach, et al.
Synapse (New York, N.Y.)|November 20, 2009
Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathwaysMichelle Taylor, Peter Grundt, Suzy A Griffin, et al.
Neuropharmacology|April 1, 2014
Pharmacological modulation of abnormal involuntary DOI-induced head twitch response in male DBA/2J mice: I. Effects of D2/D3 and D2 dopamine receptor selective compoundsClaudia Rangel-Barajas, Maninder Malik, Suwanna Vangveravong, et al.
Current Pharmaceutical Design|July 25, 2015
Bitropic D3 Dopamine Receptor Selective Compounds as Potential AntipsychoticsRobert R Luedtke, Claudia Rangel-Barajas, Mahinder Malik, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2006
Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SARPeter Grundt, Sarah Little Jane Husband, Robert R Luedtke, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Conformationally-flexible benzamide analogues as dopamine D3 and sigma 2 receptor ligandsRobert H Mach, Yunsheng Huang, Rebekah A Freeman, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Journal of Labelled Compounds & Radiopharmaceuticals|September 1, 2017
Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studiesRobert H Mach, Robert R Luedtke
The Journal of Biological Chemistry|July 13, 2004
D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascadeJun Chen, Milan Rusnak, Robert R Luedtke, et al.
Journal of Chemical Information and Modeling|October 13, 2010
Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methodsQi Wang, Robert H Mach, Robert R Luedtke, et al.
Pharmacology, Biochemistry, and Behavior|July 12, 2016
The effect of the sigma-1 receptor selective compound LS-1-137 on the DOI-induced head twitch response in miceManinder Malik, Claudia Rangel-Barajas, Robert H Mach, et al.
Neuropharmacology|February 21, 2015
Pharmacological modulation of abnormal involuntary DOI-induced head twitch response movements in male DBA/2J mice: II. Effects of D3 dopamine receptor selective compoundsClaudia Rangel-Barajas, Maninder Malik, Robert H Mach, et al.
Synapse (New York, N.Y.)|November 20, 2009
Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathwaysMichelle Taylor, Peter Grundt, Suzy A Griffin, et al.
Neuropharmacology|April 1, 2014
Pharmacological modulation of abnormal involuntary DOI-induced head twitch response in male DBA/2J mice: I. Effects of D2/D3 and D2 dopamine receptor selective compoundsClaudia Rangel-Barajas, Maninder Malik, Suwanna Vangveravong, et al.
Current Pharmaceutical Design|July 25, 2015
Bitropic D3 Dopamine Receptor Selective Compounds as Potential AntipsychoticsRobert R Luedtke, Claudia Rangel-Barajas, Mahinder Malik, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2006
Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SARPeter Grundt, Sarah Little Jane Husband, Robert R Luedtke, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Conformationally-flexible benzamide analogues as dopamine D3 and sigma 2 receptor ligandsRobert H Mach, Yunsheng Huang, Rebekah A Freeman, et al.
Pageof 7